Griffin Noreen 13D and 13G filings for Immune Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-06-07 07:06 am Purchase |
2021-05-28 | 13D | Immune Therapeutics, Inc. IMUN |
Griffin Noreen | 59,877 12.400% |
59,877 (New Position) |
Filing |